Induction of p53 and melanoma cell death is reciprocal with down- regulation of E2F, cyclin D1 and pRB

International Journal of Cancer

Volumn 76, Issue 5, 1998, Pages 757-760

  Rieber, Manuel ^a   Strasberg Rieber, Mary ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DEGRADATION; DOWN REGULATION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0031799549     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19980529)76:5<757::aid-ijc22>3.0.co;2-%23     Document Type: Article

References (35)

1. AN, B. and DOU Q.P., Cleavage of retinoblastoma protein during apoptosis: an interleukin-1β-converting enzyme-like protease as candidate. Cancer Res., 56, 438-442 (1996).
2. BATES, S., PARRY, D., BONETTA, L., VOUSDEN, K., DICKSON, C. and PETERS, G., Absence of cyclin-D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene, 9, 1633-1640 (1994).
3. DEMERS, G.W., FOSTER, S.A., HALBERT, CH.L. and GALLOWAY, D.A., Growth arrest by induction of p53 in DNA-damaged keratinocytes is bypassed by human papillomavirus 16E7. Proc. nat. Acad. Sci. (Wash.), 91, 4382-4386 (1994).
4. EL DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E. and VOGELSTEIN, B.E., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
5. EWEN, M.E., SLUSO, H.K., SHERR, C.J., MATSUSHINE, H., KATO, J. and LIVINGSTON, D.M., Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73, 487-497 (1993).
6. FRANKEN, N.A., VAN BREE, C.V., KIPP, J.B. and BARENDSEN, G.W., Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines. Int. J. Radiat. Biol., 72, 101-109 (1997).
7. GRAEBER, T.G., PETERSON, J.F., TSAI, M., MONICA, K., FORNACE, A.J. and GRACCIA, A.J., Hypoxia induces accumulation of p53 protein, but activation of a G1-phase check point by low oxygen is independent of p53 status. Mol. cell. Biol., 14, 6264-6277 (1994).
8. HALL, P.A., MCKEE, P.M., MENAGE, H.P., DOVER, R. and LANE, D.P., High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207 (1993).
9. 1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
10. HUNTER, T., Braking the cycle. Cell, 75, 839-841 (1993).
11. JUNG, J.-M., BRUNER, J.M., RUAN, S., LANGFORD, L.A., KYRITSIS, A.P., KOBAYASHI, T., LEVIN, V.A. and ZHANG, W., Increased levels of p21WAF1/CIP1 in human brain tumors. Oncogene, 11, 2021-2028 (1995).
12. LABAER, J., GARRETT, M.D., STEVENSON, L.F., SLINGERLAND, J.M., SANDHU, C., CHOU, H.S., FATTAEY, A. and HARLOW, E., New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862 (1997).
13. LU, X. and LANE, D.P., Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75, 765-778 (1993).
14. LUBBE, J., REICHEL, M., BURG, G. and KLEIHUES, P., Absence of p53-gene mutations in cutaneous melanoma. J. invest. Dermatol., 102, 819-821 (1994).
15. MATSUI, M.S. and DE LEO, V.A., Long-wave ultraviolet radiation and promotion of skin cancer. Cancer Cells, 3, 8-11 (1991).
16. MILLER, E.M., FOWLER, J.F. and KINSELLA, T.J., Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. II. Radiosensitization of human colon-cancer cells by bromodeoxyuridine. Radiation Res., 131, 90-97 (1992).
17. MORGENBESSER, S.D., WILLIAMS, B.O., JACKS, T. and DE PINHO, R., p53-dependem apoptosis produced by Rb deficiency in the developing mouse lens. Nature (Lond.), 371, 72-74 (1994).
18. RIEBER, M. and CASTILLO, M.A., Unequal forms of 140-110 kDa glycoproteins in B16 melanoma cells with differing detachment properties and metastatic behavior: influence of bromodeoxyuridine. Int. J. Cancer, 33, 765-770 (1984).
19. RIEBER, M. and RIEBER, M.S., Tumor-hypersensitive DNA enriched in c-myc sequences reacts differentially with normal and malignant genomic DNA. Biochim. biophys. Res. Comm., 169, 352-359 (1990).
20. RIEBER, M. and STRASBERG-RIEBER, M., Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B 16 melanoma terminal differentiation. Cell Growth Differentiation, 5, 1339-1346 (1994).
21. SCHREIBER, E., MATTHIAS, P., MÜLLER, M.M. and SCHAFFNER, W., Rapid detection of octamer-binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res., 17, 6419 (1989).
22. SHIO, Y., YAMAMOTO, T. and YAMAGUCHI, N., Negative regulation of Rb expression by the p53-gene product. Proc. nat. Acad. Sci. (Wash.), 89, 5206-5210 (1992).
23. 1 arrest involves pRb-related proteins and is disrupted by the HPV 16 E7 oncoprotein. Proc. nat. Acad. Sci. (Wash.), 91, 5320-5324 (1994).
24. STRASBERG-RIEBER, M. and RIEBER, M., Specific tyrosinases associated with melanoma replicative senescence and melanogenesis. Cancer Res., 53, 2469-2471 (1993).
25. STRASBERG-RIEBER, M. and RIEBER, M., UV radiation induces DNA fragmentation and cell death in B16 melanoma sensitized with bromodeoxyuridine: impaired c-jun induction and defective tyrosine phosphorylation signaling. Biochem. biophys. Res. Comm., 203, 1629-1638 (1994).
26. STRASBERG-RIEBER, M., WELCH, D.R., MIELE, M.E. and RIEBER, M., p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and PCNA in BrdU-mediated growth arrest of human melanoma cells. Cell Growth Differ., 7, 197-202 (1996).
27. 1 progression. Oncogene, 9, 2663-2674 (1994).
28. USMANI, B.A., LUNEA, J. and SHERBET, G.V., DNA repair and repair fidelity in metastatic variants of the B16 melanoma. J. cell. Biochem., 51, 336-344 (1993).
29. VALYI-NAGY, I., SHIH, I.-M., GYÖRFI, T., GREENSTEIN, D., JUHASZ, I., ELDER, D. and HERLYN, M., Spontaneous and induced differentiation of human melanoma cells. Int. J. Cancer, 54, 159-165 (1993).
30. VOGELSTEIN, B. and KINZLER, K.W., p53 function and dysfunction. Cell, 70, 523-526 (1992).
31. WAG A. S., HANNON, G.J., BEACH, D. and STILLMAN, B., The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369, 574-579 (1994).
32. WEBB, C.F., JONES, G.D.D., WARD, J.F., MOYER, D.J., AGUILERA, J.A. and LING, L.L., Mechanisms of radiosensitization in bromodeoxyuridine-substituted cells. Int. J. Radiat. Biol., 64, 695-705 (1993).
33. WEINBERG, R.A., The retinoblastoma protein and cell-cycle control. Cell, 81, 323-330 (1995).
34. XIONG, Y., HANNON, G.J., ZHANG, H., CESSO, D., KOBAYASHI, R. and BEACH, D., p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366, 701-704 (1993).
35. ZHAN, Q., CARRIER, F. and FURNACE, A., Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. cell. Biol., 13, 4242-4250 (1993).